Experiment 45986

Worktypes

PHARMACOLOGY OF EXTRACT - IN HUMANSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTILEPROTIC ACTIVITY
Administration routeORAL
OrganismLasiosiphon kraussianus (THYMELAEACEAE)
CitationTUBERY,PR:. (1969). GLYCOSIDIC EXTRACT OF LASIOSIPHON KRAUSSIANUS USEFUL AS AN ANTILEPROUS MEDICAMENT.. ()
Amount utilized
Compound isolated
DiseaseCAUSED A WHITENING OF LEPROTIC LESIONS AFTER 3-6 MONTHS OF DAILY DOSING.
Dose amount0.1 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitKG
Dose expressionDOSE
ExtractETOH(95%)EXT